Lets Talk GEVO! A firm favourite on the channel, Gevo stock has been on a crazy ride over the past year! Why has GEVO been so volatile & what can we expect in the coming weeks / months ahead? We also talk a look at some of the most recent news & their recent earnings! Is Gevo still a buy? Or are the
1 extracted signal · 1 resolved · 0 still active
Trading With CJIndependent analyst profile- Source published
- 13 Aug 2021, 17:37 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC

AI-generated source summary
The video provides a fundamental analysis of GEVO stock, trading at $5.39, down 63% from its February high of $15. The analysis discusses the most recent earnings, recognizing they were not great but potentially expected. The analysis highlights a deal where Gevo will sell renewable natural gas to BP starting in 2024, expecting cash distributions of $9 million to $16 million per year. The analysis suggests GEVO is a long-term hold stock and a potential $15.00 stock. The company possesses $567 million on the balance sheet. The analysis concludes that it's beneficial to buy the stock if one is willing to hold it for the future. It states that a $4.00 failure bound is reasonable.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Trading With CJ
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
